Elanco Closes $7B Deal for Bayer Animal Health

Greenfield-based Elanco Animal Health has closed on its $6.9 billion deal to purchase Germany-based Bayer AG, making it the world’s second-largest animal health company. Companion pets make up most of Elanco’s business, roughly $3 billion, but animal agriculture is still a critical part of the company’s bottom line. Elanco President and CEO Jeff Simmons shares insight on the deal, the new way of doing business during the pandemic and outlines his vision for the company.